Latest Interviews
Showing 1–7 of 7 interview transcripts.
Clear all filters- All-In Podcast1h 24m
H-1B Shakeup, Kimmel Apology, Autism Causes, California Hate Speech Law
Jason, Jimmy Kimmel, Biden, Dave Friedberg, Chamath Palihapitiya, David Sacks, Nick
David Sacks and Chamath Palihapitiya discuss a proposed $100,000 fee for H-1B visas intended to eliminate labor arbitrage and systemic abuses in favor of a high-skilled auction model. The dialogue also covers the Trump administration's autism research on folate receptor autoimmunity and controversial links to prenatal acetaminophen use, alongside critiques of emerging political censorship laws in California. Finally, the hosts highlight significant AI infrastructure breakthroughs, including new MIT planning frameworks and German GPU architectures that promise orders-of-magnitude improvements in energy efficiency.
- All-In Podcast1h 16m
Trump assassination attempt, Secret Service failure, Inside the RNC, VC liquidity problem
Trump, Chamath, Jason, Friedberg, Nick, Freeburg
Following a failed assassination attempt by Thomas Matthew Crooks that killed one attendee and injured others, the Republican National Convention solidified a coalition between MAGA populists and tech interests by selecting J.D. Vance as Donald Trump's vice-presidential running mate. The hosts analyzed the event's security failures, debated the impact of political rhetoric on the violence, and examined the administration's potential shift toward isolationist trade policies and regulatory changes regarding Big Tech. Simultaneously, the discussion highlighted significant venture capital developments, including Stripe's liquidity deal and Google's potential acquisition of Wiz, while predicting President Biden's imminent withdrawal from the race due to declining donor confidence.
- All-In Podcast1h 27m
E174: Inflation stays hot, AI disclosure bill, Drone warfare, defense startups & more
J-Cal, Jason, Biden, Zelenskiy, Chamath Palihapitiya, Dave Friedberg, Nick
Scheduled for September 8–10 in Los Angeles, the upcoming All-In Summit 2024 will feature a confirmed single-tier ticket structure while finalizing speaker announcements and leveraging the hosts' recent analysis of AI market shifts and global urban decay. During the event, speakers will debate critical macroeconomic pressures from persistent inflation and the structural challenges facing NVIDIA, alongside the geopolitical implications of autonomous drone warfare and new copyright legislation for generative AI. These discussions aim to synthesize complex industry dynamics, ranging from cloud computing ecosystems to the potential end of the declining interest rate era, providing attendees with a comprehensive outlook on emerging technological and financial landscapes.
- All-In Podcast1h 29m
E108: Doxing debate, Nuclear fusion breakthrough, state of the markets & more
Jason, Sacks, Chamath, Calacanis, Friedberg, Cernovich, Sachs, Freeburg, Jay Cal, Jake, Draymond, Dave Chappelle, Chris Rock, Steph Curry, Joe Lacombe, Phil Helmuth, Bill Gates, Mark Andreessen, Sam Altman, Chris Dixon, Nick
Elon Musk announced a new policy banning persistent real-time location tracking of individuals to prevent stalking, while experts debated the balance between personal safety and free speech amidst his broader moderation challenges. Simultaneously, scientists at the National Ignition Facility achieved a historic net energy gain in nuclear fusion, sparking discussions on commercialization timelines and the economic viability of fusion versus solar power. In the financial sector, a stark correction in private equity and venture capital valuations is reshaping startup strategies, with firms pivoting toward capital efficiency and private equity acquisitions as public market multiples collapse.
- All-In Podcast1h 25m
E99: Cheating scandals, Twitter updates, rapid AI advancements, Biden's pardon, Section 230 & more
Biden, Chamath, Calacanis, Friedberg, Nick, Sax, David Sacks, J Cal, Phil Helmuth, Jason
Hosts conclude their 99-episode run while addressing production overloads, a surge in cross-industry cheating scandals, and Elon Musk's strained acquisition of Twitter amidst complex financial hurdles. The panel further analyzes Tesla's AI robotics advancements, President Biden's cannabis pardons, and the Supreme Court's upcoming review of Section 230 liability as experts debate free speech frameworks. Key announcements include the upcoming "All In Meetups" in Zurich and Miami, a high-stakes poker tournament featuring Chamath Palihapitiya, and the revelation that Jason Calacanis coined the title "Data Scientist" in 2008.
- All-In Podcast1h 25m
E97: SPAC updates, public/private market overview, Putin's end game & more
Putin, Chamath, Calacanis, Friedberg, Jake, Nick, David, Jason, Sacks
Chamath Palihapitiya announced the liquidation of his IPOD and IPOF SPACs to return capital to investors, citing an unsustainable market environment where valuation gaps and volatility have frozen exits for late-stage private companies. He forecast a catastrophic "washout" for the broader SPAC sector while criticizing systemic failures in venture capital diligence and ESG frameworks that obscure financial reality. The discussion further addressed looming geopolitical risks, including escalation in Ukraine and protests in Iran, arguing that institutional decay and demographic shifts are driving instability that requires a nuanced diplomatic approach rather than intervention.
- Milken Institute58 min
The Role of Universities in Accelerating Bioscience Research
David Baltimore, Joel Burdick, James Economou, Michael Quick, Owen Witte, Stephen Mayo, Steve Mayo, Nick, Francis Collins, Remy, Joe Boistak, Charles, Eric Green, Ray Deshaies
A consortium of leading academic figures, including Nobel Laureate David Baltimore and experts from Caltech, UCLA, and USC, convened to evaluate the intersection of biological engineering and clinical translation in the face of funding constraints. The panel detailed successful strategies for "engineered immunity" projects, such as converting muscle cells into antibody producers and conducting early-stage human trials within university settings, while highlighting the critical need for interdisciplinary programs that bridge the gap between engineering PhDs and MDs. Despite progress, participants identified a persistent "valley of death" in early-stage financing and urged a cultural shift toward professional management and team-based funding mechanisms to sustain innovation.